Leukapheresis Market: Major Trends Reshaping the Future of the Industry

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Leukapheresis Industry Market Size Be by 2025?
The leukapheresis market volume has witnessed considerable expansion recently. Its growth trajectory is set to rise from $66.8 billion in 2024 to $72.02 billion in 2025 with a compound annual growth rate (CAGR) of 7.8%. Factors responsible for this robust growth during the historical phase include a growing incidence of leukemia and autoimmune diseases, surging demand for tailor-made medicine, advances in stem cell research, progression in apheresis technologies, increased activities in clinical trials, and heightened understanding of immunotherapy applications.

What's the Long-Term Growth Forecast for the Leukapheresis Market Size Through 2029?
It is anticipated that the leukapheresis market will experience robust growth in the coming few years, reaching a value of $97.11 billion in 2029 with a compound annual growth rate of 7.8%. The market's growth in the projected period can be due to factors like heightened demand for customized cell therapeutics, growing immuno-oncology clinical trials, wider acceptance in regenerative medicine as well as expansion in biopharmaceutical manufacturing. Moreover, improved insurance reimbursement policies and increased awareness about cell-based research and treatment possibilities also contribute to the growth. Prominent trends in the upcoming period are anticipated to include advancement in cell separation technology, incorporation of artificial intelligence for procedure enhancement, the growth of portable leukapheresis devices, advancements in the field of cell and gene therapy, better donor assessment methods, and the utilization of cloud-based systems for data tracking.

View the full report here:
https://www.thebusinessresearchcompany.com/report/leukapheresis-global-market-report

What Are the Key Growth Drivers Fueling the Leukapheresis Market Expansion?
The leukapheresis market is forecasted to expand due to an increase in autoimmune diseases, disorders where the body's immune system mistakenly destroys its own healthy tissue. Modern environmental elements and decreased early-life microbial exposure are resulting in a disrupted immune balance and a surge in autoimmune diseases. Leukapheresis can aid in the treatment of these diseases by selectively eliminating harmful white blood cells that are attacking the body's healthy tissues. For example, Versorgungsatlas.de, a German organization, stated that in 2022, of the 73,241,305 insured individuals, 6,304,340 had at least one diagnosed autoimmune disease, which corresponds to a raw prevalence rate of 8.61%. This increase in autoimmune conditions is thus propelling the leukapheresis market's growth.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24277&type=smp

Which Emerging Trends Are Transforming the Leukapheresis Market in 2025?
Key players in the leukapheresis market are committed to enhancing quality and efficiency through innovations such as the creation of GMP-grade leukopaks. These products, derived from leukapheresis, are manufactured under rigorous good manufacturing practice (GMP) standards, guaranteeing the high proficiency and longevity of the cells collected for therapeutic use. For illustration, Sanguine Biosciences, a biotechnology firm located in the United States, introduced LeukoCer, a GMP-grade leukopak, in November 2024 to expedite the development of cell therapies and simplify associated workflows. LeukoCert provides top-quality starting resources in both fresh whole and half packs, made in accordance with stringent GMP guidelines. This aids researchers in advancing their studies and bringing new cell therapies to market more swiftly.

How Is the Leukapheresis Market Segmented?
The leukapheresis market covered in this report is segmented -

1) By Type: Granulocyte Apheresis, Lymphocyte Apheresis, Monocyte Apheresis
2) By Product: Leukapheresis Devices, Centrifugal Devices, Membrane Separators, Leukapheresis Disposables
3) By Application: Research Application, Cancer Research, Immunology Research, Therapeutics Application, Hematologic Disorders, Autoimmune Diseases, Other Applications
4) By End User: Blood Component Providers And Blood Centers, Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Hospitals And Transfusion Centers

Subsegments:
1) By Granulocyte Apheresis: Neutrophil Apheresis, Eosinophil Apheresis, Basophil Apheresis
2) By Lymphocyte Apheresis: T-Cell Apheresis, B-Cell Apheresis, Natural Killer (NK) Cell Apheresis
3) By Monocyte Apheresis: Classical Monocytes, Non-Classical Monocytes, Intermediate Monocytes

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=24277&type=smp

Which Companies Are Leading the Charge in Leukapheresis Market Innovation?
Major companies operating in the leukapheresis market are Fresenius Kabi, Grifols S.A., Terumo BCT Inc., Nikkiso Co., STEMCELL Technologies Inc., Haemonetics Corporation, Macopharma, Discovery Life Sciences, BioIVT LLC, StemExpress LLC, MEDICA S.p.A, AllCells LLC, Caltag Medsystems Ltd., Miltenyi Biotec, Immune Therapy Holdings AB, Cellsep Laboratories, Accegen Biotec, Key Biologics LLC, HemaCare Corporation, Puriblood Medical, Cytopheron Technologies, Adacyte Therapeutics.

Which Regions Are Leading the Global Leukapheresis Market in Revenue?
North America was the largest region in the leukapheresis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the leukapheresis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24277

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.